Shares of Aldeyra Therapeutics gained after the Food and Drug Administration accepted the company's resubmitted new drug application for its treatment of dry eye disease for review. The stock rose 11% ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara® 1), an agent for the imaging of glioma. The application has been granted priority review and designated a PDUFA 2 goal date ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

must submit an NDS within 12 months of filing a New Drug Application (NDA) in the US. This requirement is established by ...